申请人:Hoechst Aktiengesellschaft
公开号:US05614537A1
公开(公告)日:1997-03-25
The invention relates 2,4- and 2,5-bistetrazolylpyridines. Said compounds inhibit the enzymes proline hydroxylase and lysine hydroxylase and bring about a selective inhibition of collagen biosynthesis. They are used as fibrosuppressants and immunosuppressants.
该发明涉及2,4-和2,5-双
四唑基
吡啶化合物。所述化合物抑制脯
氨酸羟化酶和赖
氨酸羟化酶酶,并引起
胶原蛋白生物合成的选择性抑制。它们用作纤维
抑制剂和
免疫抑制剂。